Anti-proliferative effects of phosphodiester oligodeoxynucleotides

Immunobiology

Volumn 209, Issue 8, 2004, Pages 637-645

  Bjersing, Jan L ^a   Tarkowski, Andrej ^a   Collins, L Vincent ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CpG ODN; IL 10; Phosphodiester; Phosphorothioate; Suppressive

Indexed keywords

CYTOSINE; DEOXYRIBONUCLEASE I; GUANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE; PHOSPHATE; PHOSPHODIESTER OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; FEMALE; FREQUENCY ANALYSIS; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MEDICAL DOCUMENTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SUPERNATANT; UPREGULATION;

EID: 11244309091     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2004.09.005     Document Type: Article

References (22)

1. Bergquist, J., Ohlsson, B., Tarkowski, A., 2000. Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann. N.Y. Acad. Sci. 917, 281-289.
2. Bhagat, L., Zhu, F.G., Yu, D., Tang, J., Wang, H., Kandimalla, E.R., Zhang, R., Agrawal, S., 2003. CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents. Biochem. Biophys. Res. Commun. 300, 853-861.
3. Chen, Y., Lenert, P., Weeratna, R., McCluskie, M., Wu, T., Davis, H.L., Krieg, A.M., 2001. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 8, 1024-1032.
4. Dalpke, A.H., Zimmermann, S., Albrecht, I., Heeg, K., 2002. Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 106, 102-112.
5. Ghosh, S., May, M.J., Kopp, E.B., 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16, 225-260.
6. Gross, J.A., Johnston, J., Mudri, S., Enselman, R., Dillon, S.R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W., Clegg, C.H., 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999.
7. Gross, J.A., Dillon, S.R., Mudri, S., Johnston, J., Littau, A., Roque, R., Rixon, M., Schou, O., Foley, K.P., Haugen, H., McMillen, S., Waggie, K., Schreckhise, R.W., Shoemaker, K., Vu, T., Moore, M., Grossman, A., Clegg, C.H., 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease impaired B cell maturation in mice lacking BLyS. Immunity 15, 289-302.
8. Hartmann, G., Weiner, G.J., Krieg, A.M., 1999. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96, 9305-9310.
9. Krieg, A.M., 2002. CpG motifs in bacterial DNA and their immune effects. Ann. Rev. Immunol. 20, 709-760.
10. Krieg, A.M., Wu, T., Weeratna, R., Efler, S.M., Love-Homan, L., Yang, L., Yi, A.K., Short, D., Davis, H.L., 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95, 12631-12636.
11. Lenert, P., Stunz, L., Yi, A.K., Krieg, A.M., Ashman, R.F., 2001. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides, at a site proximal to NF-kappaB activation. Antisense Nucl. Acid Drug Dev. 11, 247-256.
12. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., O'Garra, A., 2001. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19, 683-765.
13. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., Moroy, T., 2000. Features of systemic lupus erythematosus in DNase 1-deficient mice. Nat. Genet. 25, 177-181.
14. Pisetsky, D.S., Reich, C.F., 2000. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin. Immunol. 96, 198-204.
15. Redford, T.W., Yi, A.K., Ward, C.T., Krieg, A.M., 1998. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J. Immunol. 161, 3930-3935.
16. Sester, D.P., Naik, S., Beasley, S.J., Hume, D.A., Stacey, K.J., 2000. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 165, 4165-4173.
17. Stunz, L.L., Lenert, P., Peckham, D., Yi, A.K., Haxhinasto, S., Chang, M., Krieg, A.M., Ashman, R.F., 2002. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 32, 1212-1222.
18. Yamada, H., Gursel, I., Takeshita, F., Conover, J., Ishii, K.J., Gursel, M., Takeshita, S., Klinman, D.M., 2002. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169, 5590-5594.
19. Yi, A.K., Yoon, J.G., Yeo, S.J., Hong, S.C., English, B.K., Krieg, A.M., 2002. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 168, 4711-4720.
20. Zenner, R.A., Ishii, K.J., Lizak, M.J., Gursel, I., Yamada, H., Klinman, D.M., Verthelyi, D., 2002. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum. 46, 2219-2224.
21. Zhao, Q., Matson, S., Herrera, C.J., Fisher, E., Yu, H., Krieg, A.M., 1993. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53-66.
22. Zhu, F.G., Reich, C.F., Pisetsky, D.S., 2002. Inhibition of urine macrophage nitric oxide production by synthetic oligonucleotides. J. Leukoc. Biol. 71, 686-694.